Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

People with schizophrenia have lower zinc, copper, and chromium in their hair.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Toll-like receptor 3 helps repair the skin barrier after UV damage.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

TRPV3 in skin cells causes inflammation and cell death.

Reduced cytokinin levels help plants adapt to low potassium by increasing root hair growth and potassium uptake.

Ajwain seed extract improved skin healing and hair growth in a mouse skin irritation model.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Bojungikki-tang may help with hair regrowth during chemotherapy.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Using both DLQI and Skindex-16 together gives a better understanding of quality of life in skin disease patients.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

The man was diagnosed with stage III multiple myeloma and treated to improve kidney function.

Combining oral minoxidil with JAK inhibitors helps regrow hair in severe alopecia areata cases.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

Most end-stage renal disease patients in Jordan have skin issues like dryness and itching.

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

A mutation in the IKZF1 gene causes immune system overactivity, linked to autoimmune diseases like lupus.

Vitamin B6 may help activate dormant follicles.

Using a specific binding agent and low doses of FK506 can stimulate stem cells, speeding up skin healing by 25% and improving skin quality in rats and mice.